Page last updated: 2024-08-21

azomycin and Leishmaniasis

azomycin has been researched along with Leishmaniasis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braillard, S; Caljon, G; Chatelain, E; Hendrickx, S; Mabille, D; Maes, L; Mowbray, CE; Van den Kerkhof, M1
Aguiar, MMG; de Morais-Teixeira, E; Rabello, A1
Alakurtti, S; Brun, R; Jaffe, CL; Kaiser, M; Kopelyanskiy, D; Moreira, VM; Nasereddin, A; Oksman-Caldentey, KM; Pirttimaa, M; Yli-Kauhaluoma, J1
Agil, A; Alvarez-Manzaneda, E; Chahboun, R; Es-Samti, H; Fernández, A; Guardia, JJ; Marín, C; Ramírez-Macías, I; Sánchez-Moreno, M; Zentar, H1
Barrett, MP; Croft, SL1
Bandyopadhyay, D; Banik, BK; Nogueda-Torres, B; Rivera, G; Samano, S; Sanchez-Torres, LE; Villalobos-Rocha, JC1
Fragata-Filho, AA; Levy, AM; Pereira-Chioccola, VL; Rodrigues, MM; Schenkman, S1

Reviews

1 review(s) available for azomycin and Leishmaniasis

ArticleYear
Management of trypanosomiasis and leishmaniasis.
    British medical bulletin, 2012, Volume: 104

    Topics: Administration, Oral; Africa; Amphotericin B; Antiprotozoal Agents; Benzamides; Boron Compounds; Chagas Disease; Drug Therapy, Combination; Humans; India; Leishmaniasis; Nitroimidazoles; Pentamidine; Triazoles; Trypanosomiasis, African

2012

Other Studies

6 other study(ies) available for azomycin and Leishmaniasis

ArticleYear
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
    International journal for parasitology. Drugs and drug resistance, 2018, Volume: 8, Issue:1

    Topics: Animals; Antimony; Antiprotozoal Agents; Boron Compounds; Cricetinae; Female; Inhibitory Concentration 50; Leishmania donovani; Leishmania infantum; Leishmaniasis; Mice; Nitroimidazoles; Parasitic Sensitivity Tests; Pyrazoles

2018
In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species.
    The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8

    Topics: Administration, Oral; Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmania; Leishmaniasis; Male; Mesocricetus; Mice, Inbred BALB C; Nitroimidazoles

2019
Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi.
    Journal of natural products, 2016, Feb-26, Volume: 79, Issue:2

    Topics: Abietanes; Amides; Chagas Disease; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Macrophages; Molecular Structure; Nitroimidazoles; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi

2016
Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
    Parasitology international, 2012, Volume: 61, Issue:3

    Topics: Abietanes; Animals; Cell Line; Chagas Disease; Female; Fluorenes; Leishmania braziliensis; Leishmania infantum; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Nitroimidazoles; Quinones; Trypanocidal Agents; Trypanosoma cruzi

2012
A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
    Current medicinal chemistry, 2017, Volume: 24, Issue:41

    Topics: Amphotericin B; Antiprotozoal Agents; Benzimidazoles; Chagas Disease; Green Chemistry Technology; Heating; Leishmania mexicana; Leishmaniasis; Microwaves; Nifurtimox; Nitroimidazoles; Trypanosoma cruzi

2017
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.
    Clinical and diagnostic laboratory immunology, 2003, Volume: 10, Issue:5

    Topics: Adult; Animals; Antibodies, Protozoan; Chagas Disease; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Glycoproteins; Humans; Immunoblotting; Leishmaniasis; Neuraminidase; Nitroimidazoles; Recombinant Proteins; Sensitivity and Specificity; Treatment Outcome; Trypanocidal Agents

2003